Earn CME: https://naccme.com/program/7317
In this presentation from the ‘Evaluating the Role of PI3K Inhibitors in Follicular Lymphoma: Highlighting the Diversity and Impact of an Emerging Therapeutic Class symposium, Dr. John P. Leonard provides an update on new data on upfront and maintenance therapy for the treatment of follicular lymphoma.
© 2018 Imedex, an HMP Company
Advertisement